湖南新五丰股份有限公司章程 湖 南 新 五 丰 股 份 有 限 公 司 章 程 (2025 年修订) 目 录 第六章 董事会 1 第一章 总则 第二章 经营宗旨和范围 第三章 股份 第一节 股份发行 第二节 股份增减和回购 第三节 股份转让 第四章 股东和股东会 第一节 股东 第二节 控股股东和实际控制人 第三节 股东会的一般规定 第四节 股东会的召集 第五节 股东会提案与通知 第六节 股东会的召开 第七节 股东会的表决和决议 第五章 公司党委 第一节 董事 第二节 董事会 第三节 独立董事 第四节 董事会专门委员会 第七章 高级管理人员 第八章 财务会计制度、利润分配和审计 湖南新五丰股份有限公司章程 第九章 通知与公告 第十二章 附则 第一章 总则 第一条 为规范湖南新五丰股份有限公司(以下简称"公司")的组织和行为，坚 持和加强党的全面领导，完善公司法人治理结构，建设中国特色现代企业制度，保障 股东、公司、职工、债权人的合法权益，促进公司的发展，根据《中华人民共和国公 司法》(以下简称《公司法》)、《中华人民共和国企业国有资产法》(以下简称《国有 资产法》)、《中国共产党章程》(以下简称《党章》)、《中 ...

证券代码：600975 证券简称：新五丰 公告编号：2025-027 湖南新五丰股份有限公司 关于修改《公司章程》并取消监事会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2025 年 6 月 6 日，湖南新五丰股份有限公司（以下简称"公司"）第六届董 事会第十七次会议以 7 票同意，0 票反对，0 票弃权，审议通过了《关于修订〈公 司章程〉并取消监事会的预案》。 根据《中华人民共和国公司法》及中国证券监督管理委员会发布的《上市公 司章程指引（2025 年修订）》《上市公司治理准则（2025 年修订）》等法律法规、 规范性文件的规定，结合公司生产经营的实际情况，拟对《湖南新五丰股份有限 公司章程》部分条款进行修订。 本次《公司章程》修订完成后，公司将不再设置监事会，监事会的职权由董 事会审计委员会行使，《公司监事会议事规则》相应废止。具体修订内容如下： | 序号 | 原条款 | 修订后的条款 | | --- | --- | --- | | 1 | 第一条 | 第一条 | | | 为规范湖南新五丰股份有限 | 为规范湖 ...

湖南新五丰股份有限公司年报 信息披露重大差错责任追究制度 （修订稿） 第一章 总 则 第一条 为了提高湖南新五丰股份有限公司（以下简称"公司"）的规范运 作水平，增强信息披露的真实性、准确性、完整性和及时性，提高年报信息披 露的质量和透明度，根据《中华人民共和国公司法》《中华人民共和国证券法》 《上市公司信息披露管理办法》等法律、行政法规、规范性文件及《公司章程》 《公司信息披露事务管理制度》的有关规定，结合公司实际情况，制订本制度。 第二条 本制度所指责任追究制度是指年报信息披露工作中有关人员不履 行或者不正确履行职责、义务或其他个人原因，对公司造成重大经济损失或造 成不良社会影响时的追究与处理制度。 第三条 本制度适用于公司董事、高级管理人员、各职能部门负责人、各 分子公司负责人、控股股东及实际控制人以及与年报信息披露工作有关的其他 人员。 第四条 实行责任追究，应遵循以下原则：实事求是、客观公正、有错必 究；过错与责任相适应；责任与权利对等。 第五条 公司证券事务部在董事会秘书领导下负责收集、汇总与追究责任 有关的资料，按制度规定提出相关处理方案，上报公司董事会批准。 第二章 年报信息披露重大差错的责任 ...

证券代码：600975 证券简称：新五丰 公告编号：2025-028 2025 年 6 月 6 日，公司第六届董事会第十七次会议以 7 票同意，0 票反对，0 票弃权， 通过了《关于注销湖南新五丰股份有限公司湘乡分公司的议案》。 本次注销事项不涉及关联交易，也不构成重大资产重组。 三、注销原因和对公司的影响 本次注销事项为进一步加强公司整体战略规划，整合和优化现有资源配置，降低管理 成本，从而提高公司的运营效率及整体经营效益。 湖南新五丰股份有限公司 关于注销湖南新五丰股份有限公司湘乡分公司的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 为进一步加强湖南新五丰股份有限公司（以下简称"公司"）整体战略规划，整合和优 化现有资源配置，降低管理成本，从而提高公司的运营效率及整体经营效益，公司拟注销 湖南新五丰股份有限公司湘乡分公司（以下简称"湘乡分公司"），并授权公司经营管理层 依法规定办理湘乡分公司注销的各项工作。 一、拟注销分公司的基本情况 名称：湖南新五丰股份有限公司湘乡分公司 经营场所：湘乡市白田镇高冲村二亩冲村民组 ...

证券代码：600975 证券简称：新五丰 公告编号：2025-029 湖南新五丰股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东大会类型和届次 2024年年度股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 6 月 27 日 9 点 召开地点：湖南省长沙市五一西路 2 号"第一大道"19 楼会议室 股东大会召开日期：2025年6月27日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (五)网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 27 日 (六)融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者 的投票，应按 ...

湖南新五丰股份有限公司第六届董事会 第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 湖南新五丰股份有限公司（以下简称"公司"或"新五丰"）第六届董事会 第十七次会议于 2025 年 6 月 6 日（周五）以通讯方式召开。公司董事 7 名，实 际参加表决董事 7 名。会议召开程序符合《公司法》《公司章程》及其他法律法 规的规定。 证券代码：600975 证券简称：新五丰 公告编号：2025-026 1、关于修订《公司章程》并取消监事会的预案 以同意票 7 票，反对票 0 票，弃权票 0 票通过了该预案，内容详见上海证券 交易所网站 www.sse.com.cn 上《湖南新五丰股份有限公司关于修订〈公司章程〉 并取消监事会的公告》，公告编号：2025-027 及《湖南新五丰股份有限公司章 程》（2025 年修订）。 此预案尚须股东大会审议通过。 2、关于修改《湖南新五丰股份有限公司董事会秘书工作细则》的议案 以同意票 7 票，反对票 0 票，弃权票 0 票通过了该议案，内容详见上海证券 交易所网站 www.s ...

Core Viewpoint - The article highlights the journey and contributions of Wang Hongling, a feed formulation expert at Hunan New Wufeng Co., Ltd., in the pig farming industry, emphasizing her role in cost reduction and innovation in feed formulation amidst fluctuating raw material prices [1][4][6]. Group 1: Company Overview - Hunan New Wufeng Co., Ltd. specializes in pig farming and meat product sales, transitioning from primarily supplying Hong Kong and Macau to also supplying fresh pork and meat products to mainland China [8]. - The company has expanded its scale in feed production and pig farming, with an output of nearly 4.25 million pigs in 2024, supplying over 4.18 million to the mainland [8]. Group 2: Industry Challenges and Innovations - The pig farming industry faces significant cost pressures, with feed accounting for 60% to 70% of total costs [6]. - Wang Hongling successfully implemented a feed formulation strategy that replaced corn with wheat, reducing costs by 150-300 yuan per ton [6]. - In response to the surge in soybean meal prices due to the Russia-Ukraine conflict, the company adopted low-protein diet technology, decreasing soybean meal usage from 15% to below 5% [6]. Group 3: Professional Development and Research - Wang Hongling pursued advanced studies, earning a Ph.D. in Animal Production and Animal Husbandry Engineering, becoming the first Ph.D. nurtured by the company [7]. - The company emphasizes continuous improvement in research and development to enhance feed quality and production efficiency, reflecting a commitment to advancing China's feed and livestock standards [10].

Group 1 - BYD reported August sales of 174,915 new energy vehicles, a year-on-year increase of 184.84% [1] - Cumulative sales from January to August reached 978,795 units, representing a year-on-year growth of 267.31% [1] - The company sold 5,092 new energy passenger vehicles overseas in August [1] Group 2 - Zhongke Electric's subsidiary plans to establish a joint venture with Chongqing Fudi for the production of anode materials, with a registered capital of 1 billion RMB [2] - Zhongke Electric's subsidiary will contribute 650 million RMB, while Chongqing Fudi will contribute 350 million RMB [2] Group 3 - Yuyuan Group intends to transfer 13% of its shares in Jinhuijiu for approximately 1.937 billion RMB, reducing its stake to 25% [3] - The company plans to further reduce its holdings by more than 5% within the next six months [3] Group 4 - Lizhu Group's recombinant COVID-19 fusion protein vaccine has been included in the emergency use for sequential booster immunization [4] Group 5 - Guanghui Energy plans to repurchase shares worth between 800 million and 1 billion RMB to support employee stock ownership plans [5] Group 6 - Cambrian has launched four cloud-based intelligent chips, although mass sales will require a longer time frame and initial technical service investments [7] Group 7 - LePu Medical has received approval from the China Securities Regulatory Commission for the issuance of Global Depositary Receipts (GDRs) and listing on the Swiss Stock Exchange [9] - The GDR issuance will correspond to no more than 180,458,875 new A-shares [9] Group 8 - Fushi Holdings' subsidiary has entered into an exclusive advertising agency cooperation with the Central Radio and Television Station's automotive channel for three years [10] Group 9 - Guangzhou Port's container throughput in August was 1.981 million TEUs, a year-on-year increase of 2.4% [11] - The total cargo throughput for August was 44.788 million tons, a decrease of 0.6% [11] Group 10 - Ningbo Port expects to complete a container throughput of 3.58 million TEUs in August, a year-on-year increase of 10.2% [12] - The total cargo throughput is projected to decline by 3.0% [12] Group 11 - Ming Tai Aluminum reported a 7% year-on-year decrease in aluminum plate and strip sales in August, while aluminum profile sales increased by 47% [13] Group 12 - Electric Power Investment plans to invest in multiple wind and solar projects, with total static investments of 1.585 billion RMB for wind and 538 million RMB for solar [14] Group 13 - Northeast Pharmaceutical has signed a cooperation agreement with MedAbome for the development of the MAb11-22.1 antibody project [19] Group 14 - New Five Feng plans to acquire equity in Tianxin Seed Industry and several other companies for a total price of approximately 2.208 billion RMB [26] Group 15 - Sumeida's subsidiary plans to transfer 100% equity of eight photovoltaic power station project companies, with an estimated transaction value of 657 million RMB [27] Group 16 - *ST Tongzhou intends to acquire 51% equity in Tongtaiwei, fulfilling the capital contribution obligation of 10.2 million RMB [29] Group 17 - Tianyin Holdings' subsidiary plans to invest 120 million RMB in Xundong Xintong to acquire 40% equity [30] Group 18 - Hainan Haiyao plans to publicly transfer 43% equity in Shanghai Lishengte to attract new investors [31] Group 19 - New Asia Process plans to transfer 7.76% of its shares to Xiangcai New Materials at a price of 5.274 RMB per share [32] Group 20 - Lanwei Medical plans to raise no more than 664 million RMB through a private placement for provincial laboratory construction projects [34] Group 21 - Lida New Materials plans to issue convertible bonds to raise no more than 300 million RMB for a new aluminum material project [35] Group 22 - Gekewei has successfully launched its 12-inch CIS integrated circuit project, achieving over 95% yield [51] Group 23 - Baijin Medical's tricuspid valve ring product has received registration approval [52] Group 24 - Shanghai Pharmaceuticals has received approval to initiate Phase I clinical trials for a recombinant anti-CD20 humanized monoclonal antibody [53] Group 25 - Junda Co. has increased the production capacity of its solar cell production base project from 8GW to 10GW [54]

Group 1 - Lingyun Optics' actual controller promises not to reduce shareholdings for 12 months starting from July 7, 2025 [1] - Chengdi Xiangjiang's subsidiary signed a contract with China Mobile for a data center project worth 1.632 billion yuan, with a 92-day construction period starting April 30, 2025 [1] - Dingyang Technology launched a high-end arbitrary waveform generator with a maximum output frequency of 5 GHz, catering to communication, industrial, and research testing needs [2][3] Group 2 - Heng Rui Medicine completed a share repurchase plan, buying back 12.9051 million shares for 601 million yuan, representing 0.20% of total shares [4][5] - ST Xiangxue received approval for clinical trials of TAEST1901 injection for treating advanced gastric cancer [5] - Yuyue Medical's subsidiary received EU MDR certification for its AED product, valid until May 11, 2030 [6][7] Group 3 - HNA Holding reported a 10.33% year-on-year increase in passenger revenue kilometers for April [8] - Springhui Zhikong's subsidiary terminated its listing on the National Equities Exchange and Quotations [9] - Delin Hai's shareholder plans to reduce holdings by up to 3%, equating to 3.39 million shares [10] Group 4 - Weiye Co. announced that two shareholders plan to reduce their holdings by up to 2% [12] - Green Alliance Technology's major shareholder intends to reduce holdings by up to 3% [14] - Luzhou Development Group increased its stake in Luzhou Tianhua by 1.02%, acquiring 15.9557 million shares [16] Group 5 - Hualan Pharmaceutical's subsidiary plans to acquire a 42.82% stake in Sanjing Qianhe for 23.446 million yuan [17] - Ganfeng Lithium's directors and executives plan to invest 30.8 million yuan in Shenzhen Yichu [19] - Zhonghong Medical's subsidiary is expected to be selected for a centralized procurement project [20] Group 6 - Jinkai Biotechnology's Blue Zone Fund plans to reduce holdings by up to 3% [21] - Hangxin Technology's former controlling shareholder intends to reduce holdings by up to 3% [22] - Galaxy Magnet's director plans to reduce holdings by up to 0.79% [23] Group 7 - Zhuoyue Technology's controlling shareholder's shares will be auctioned due to judicial proceedings [24] - Xinwufeng is forming a joint venture with France's Coplison Group with a registered capital of 80 million yuan [25] - Zhongcheng Co. is planning to issue shares to acquire 100% of a clean energy company, leading to a temporary stock suspension [26][27]

证券代码：600975 证券简称：新五丰 公告编号：2025- 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 投资标的名称：湖南新五丰股份有限公司（以下简称"新五丰"）与法 国科普利信集团（以下简称"科普利信"）拟成立合资公司湖南五丰利信育种公 司（暂定名，以下简称"合资公司"）。 ● 投资金额：该合资公司注册资本 8,000 万元，其中：新五丰以货币出资 的 49%。 ● 相关风险提示：本次设立合资公司尚需办理工商注册登记相关手续。未 来经营过程中，可能面对宏观政策调控、市场变化、经营管理等方面因素的影 响，导致投资收益存在不确定性的风险。 ● 其他事项：上述对外投资事项，不构成关联交易，也不构成上市公司重 大资产重组。 一、对外投资概述 （一）对外投资基本情况 新五丰与科普利信拟成立合资公司开展联合育种项目合作，该合资公司注 册资本 8,000 万元，其中：新五丰以货币出资 4,080 万元，占注册资本的 51%； 科普利信以货币出资 3,920 万元，占注册资本的 49%，新五丰与科普利信成立 合资 ...